Arginine-glycine-aspartate (RGD)-targeted positron-labeled dendritic polylysine nanoprobe for tumor PET imaging.

导出 OA

翻译打印收藏纠错

作者： Qi,Fang ^[1] ; Yongcheng,Xiao ^[2] ; Rongqin,Zhang ^[3] ; Jilin,Yin ^[3] ; Deming,Xie ^[2] ; Xinlu,Wang ^[1]

作者单位： Department of Nuclear Medicine, The First Clinical Hospital of Guangzhou Medical University Guangzhou 510120 China 71Lu@163.com. ^[1] Key Laboratory of Biomaterials of Guangdong Higher Education Institutes, Guangdong Provincial Engineering and Technological Research Center for Drug Carrier Development, Department of Biomedical Engineering, Jinan University Guangzhou 510632 China bme2004@126.com. ^[2] Department of Nuclear Medicine, General Hospital of Southern Theater Command, PLA Guangzhou 510010 China. ^[3]

DOI 10.1039/d0ra02813d

PMID 35520297

发布时间 2022-07-16

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

RSC advances

2020年10卷39期

23276-23285页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Arginine-glycine-aspartate (RGD)-targeted positron-labeled dendritic polylysine nanoprobe for tumor PET imaging.

RSC advances

相似文献

RSC advances

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Arginine-glycine-aspartate (RGD)-targeted positron-labeled dendritic polylysine nanoprobe for tumor PET imaging.

RSC advances

相似文献

RSC advances

相关期刊

检索历史清除